Kraig Biocraft Laboratories Announces Results of 2013 Meeting of Shareholders

LANSING, Mich., April 17, 2013 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the "Company"), the leading developer of advanced spider silk based fibers, announced today that all of the Board of Director's proposals were approved at its meeting of shareholders held yesterday in Lansing, Michigan.

All three amendments to Company's charter listed on the meeting agenda passed with unanimous attending shareholder approval. The amendments were designed to help management advance the business model in a more streamlined fashion.

"The overwhelming support of the attending shareholders, expressed over nearly four hours of discussions, and the unanimous vote on all of management's proposals, is a validation of our plans for production and commercialization," said CEO and founder Kim Thompson. "I am looking forward to communicating further details of our plans and progress to the shareholders in an upcoming shareholder conference call."

"I would like to thank the shareholders who were able to take time out of their busy schedules to attend the meeting," continued Thompson. "It was extremely gratifying to meet other shareholders, who share many of the same visions and goals for the Company and the technology."

A copy of the three amendments to the Company charter which were approved by the shareholders at yesterday's meeting is available on the Company's website under the notice of meeting section.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT: Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com

Source:Kraig Biocraft Laboratories, Inc

More From Press Releases